These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11799338)

  • 1. Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia.
    Addington D; Addington J; Patten S; Remington G; Moamai J; Labelle A; Beauclair L
    J Clin Psychopharmacol; 2002 Feb; 22(1):20-5. PubMed ID: 11799338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
    Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B
    Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.
    Mulholland C; Lynch G; King DJ; Cooper SJ
    J Psychopharmacol; 2003 Mar; 17(1):107-12. PubMed ID: 12680747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.
    Rossini D; Serretti A; Franchini L; Mandelli L; Smeraldi E; De Ronchi D; Zanardi R
    J Clin Psychopharmacol; 2005 Oct; 25(5):471-5. PubMed ID: 16160624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Sertraline in Patients With Major Depressive Disorder Naive to Selective Serotonin Reuptake Inhibitors: A 10-Week Randomized, Multicenter, Placebo-Controlled, Double-Blind, Academic Clinical Trial.
    Valle-Cabrera R; Mendoza-Rodríguez Y; Robaina-García M; Ballesteros J; Cordero-Jiménez JR; Espinosa-Rodríguez NB; Sotolongo-Garcia Y; Lauria-Horner B;
    J Clin Psychopharmacol; 2018 Oct; 38(5):454-459. PubMed ID: 30106883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and acceptability of tianeptine and sertraline in the acute treatment phase of depression].
    Szádóczky E; Füredi J
    Encephale; 2002; 28(4):343-9. PubMed ID: 12232543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline versus imipramine to prevent relapse in chronic depression.
    Koran LM; Gelenberg AJ; Kornstein SG; Howland RH; Friedman RA; DeBattista C; Klein D; Kocsis JH; Schatzberg AF; Thase ME; Rush AJ; Hirschfeld RM; LaVange LM; Keller MB
    J Affect Disord; 2001 Jun; 65(1):27-36. PubMed ID: 11426506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial.
    Mowla A; Dastgheib SA; Razeghian Jahromi L
    Clin Drug Investig; 2016 Jul; 36(7):539-43. PubMed ID: 27071759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
    Lustman PJ; Clouse RE; Nix BD; Freedland KE; Rubin EH; McGill JB; Williams MM; Gelenberg AJ; Ciechanowski PS; Hirsch IB
    Arch Gen Psychiatry; 2006 May; 63(5):521-9. PubMed ID: 16651509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
    Michelson D; Adler LA; Amsterdam JD; Dunner DL; Nierenberg AA; Reimherr FW; Schatzberg AF; Kelsey DK; Williams DW
    J Clin Psychiatry; 2007 Apr; 68(4):582-7. PubMed ID: 17474814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
    J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
    J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertraline treatment of co-occurring alcohol dependence and major depression.
    Kranzler HR; Mueller T; Cornelius J; Pettinati HM; Moak D; Martin PR; Anthenelli R; Brower KJ; O'Malley S; Mason BJ; Hasin D; Keller M
    J Clin Psychopharmacol; 2006 Feb; 26(1):13-20. PubMed ID: 16415699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder.
    Lépine JP; Caillard V; Bisserbe JC; Troy S; Hotton JM; Boyer P
    Am J Psychiatry; 2004 May; 161(5):836-42. PubMed ID: 15121648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?
    Trivedi MH; Rush AJ; Carmody TJ; Donahue RM; Bolden-Watson C; Houser TL; Metz A
    J Clin Psychiatry; 2001 Oct; 62(10):776-81. PubMed ID: 11816866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study.
    Amidfar M; Khiabany M; Kohi A; Salardini E; Arbabi M; Roohi Azizi M; Zarrindast MR; Mohammadinejad P; Zeinoddini A; Akhondzadeh S
    J Clin Pharm Ther; 2017 Feb; 42(1):44-50. PubMed ID: 27809351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.